Industry Insights

Olson Research is thrilled to announce that Paul Allen has been appointed Vice President of the Pharmaceutical Marketing Research Group (PMRG) for 2016.
(more…)

Tags:

• Rare Disease

Olson Research Group and Currant Insights recently partnered to better understand rare disease stakeholder dynamics.

After an initial round of exploratory research focused on three rare conditions, we expanded the research scope to survey 845 physicians treating ten rare conditions to further test our hypothesis and refine our model. Results from the research were presented at the 2014 PMRG Institute. This infographic details three key insights into rare disease stakeholder dynamics. (more…)

Tags:

• Cancer,
• Oncology

Some Oncologists are now being offered $350 per patient each month to follow an insurer’s recommended treatment protocol but many are concerned that this will inhibit quality patient care. We asked Oncologists their opinions on the matter and here’s what they had to say. (more…)

What are healthcare practitioners currently doing to utilize mHealth tools in their clinical practice? Who is adopting these tools and technologies? How are they being harnessed to improve patient access to care? What opportunities and obstacles might the future hold? (more…)

Tags:

• specialists

Industry Insights Volume 4: Issue 6

Using our internet-based tool OlsonOnline™, fueled by the engine of our proprietary healthcare database, Olson Research surveyed more than 1,200 HCPs of various specialties to see how they were adapting to the current reforms and how well they understood the reform plans. The answers may not be what you expected.

(more…)

Tags:

• HCP,
• HIT,
• market research

Electronic Health Records Adoption, Platform, Utility, and Practice Management

EHRs are a critical part of the practice of medicine in the post-ACA era; the more we understand how HCPs feel about EHRs and how HCPs are using the technology, the better equipped we will be as researchers to leverage the platforms and the data garnered by them. The opportunity to integrate research instruments and to collaborate with the technology partners in the HIT world will be one of the next big steps in market research for the life sciences industry.

(more…)

Industry Insights Volume 4: Issue 5

Using our new mobile-based survey platform, OlsonOnline™, and fueled by our proprietary healthcare database, Olson Research recently surveyed US physicians to learn more about which physicians were adapting to using mobile marketing research survey tools and how they were utilizing this new technology. The answers may not be what you expected.

(more…)

Tags:

• PCP,
• specialists

Industry Insights Volume 4: Issue 4

Using our internet-based tool OlsonOnline™, fueled by the engine of our proprietary healthcare database, Olson Research surveyed more than 1,600 US healthcare professionals, including a mix of PCPs, specialists, and NP/PAs from solo, group, and hospital-based practices in January 2013. The objective for the research pieces was to delve deeper into the EHR platforms that are most commonly used by healthcare professionals in this increasingly crowded industry. It is worth noting that 79% of respondents are currently using EHRs, 42% of EHR Non-users are most likely to be solo practitioners and 76% of respondents have been using EHRs for more than one year.

(more…)

Industry Insights Volume 4: Issue 3

Our recent research on Electronic Health Records (EHR) has uncovered some unexpected trends associated with adoption, utility, and impact on practice management. While EHR platforms offer the promise of increasing efficiency and improving patient care, are physicians really utilizing EHR to achieve this goal? The answers may surprise you.

(more…)

Tags:

• patient standards

Industry Insights Volume 4: Issue 2

In the second part to our EHR series, we look at the utility of EHR systems and find that there is a large gap between the utility value of EHR platform between current users and future adopters. Among EHR users, applications that could improve patient standards of care are most valuable; not so among future EHR adopters.

(more…)